Ondansetron HCL 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQ75K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,155
Award facts
- Contract value 100% obligated
- $22,155.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ondansetron HCl 8 mg tablets (30-count units) with a ceiling value of $22,155.02. This firm fixed-price delivery order, which is expected to be completed by September 17, 2025, carries no set-aside designation and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a widely-used antiemetic medication commonly prescribed to prevent nausea and vomiting, particularly in military and veteran healthcare settings supported by the Defense Health Agency.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards with the DLA, demonstrating its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ75K?
SPE2DB25FQ75K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FQ75K worth?
The government has obligated $22,155 on SPE2DB25FQ75K.
Is contract SPE2DB25FQ75K an order under another contract?
Yes. SPE2DB25FQ75K is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ75K competed?
The extent of competition for SPE2DB25FQ75K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award